info@synchemia.com | sales@synchemia.com 
9766925136 
Cobimetinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Cobimetinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso Impurity 1 CAS NO:NAchemically represented as (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(piperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso Impurity 1.We supply Cobimetinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N014550 |
| CAS No | NA |
| Mol.F. | C22H23BrFN5O3 |
| Mol.Wt. | 504.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014551 |
| CAS No | NA |
| Mol.F. | C17H10F6N8O2 |
| Mol.Wt. | 472.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014552 |
| CAS No | NA |
| Mol.F. | C10H11N3O2 |
| Mol.Wt. | 205.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014553 |
| CAS No | NA |
| Mol.F. | C9H18N2O |
| Mol.Wt. | 170.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014555 |
| CAS No | NA |
| Mol.F. | C9H7ClN6OS |
| Mol.Wt. | 282.71 |
| INV STATUS | In Stock |
| CAT No | SRC-N014556 |
| CAS No | NA |
| Mol.F. | C24H27N3O4 |
| Mol.Wt. | 421.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014557 |
| CAS No | 3038740-94-9 |
| Mol.F. | C15H23N3O3 |
| Mol.Wt. | 293.4 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014558 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.4 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014559 |
| CAS No | NA |
| Mol.F. | C19H13F2N7O2 |
| Mol.Wt. | 409.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014560 |
| CAS No | NA |
| Mol.F. | C29H25ClFN5O5S |
| Mol.Wt. | 610.06 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014561 |
| CAS No | NA |
| Mol.F. | C29H24ClFN6O6S |
| Mol.Wt. | 639.05 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014562 |
| CAS No | NA |
| Mol.F. | C27H34N8O5S |
| Mol.Wt. | 582.68 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014563 |
| CAS No | NA |
| Mol.F. | C15H18ClN5O3S |
| Mol.Wt. | 383.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014564 |
| CAS No | NA |
| Mol.F. | C23H26N8O5S |
| Mol.Wt. | 526.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014565 |
| CAS No | NA |
| Mol.F. | C16H12N4O4 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014566 |
| CAS No | 364745-13-1 |
| Mol.F. | C8H4N2O3 |
| Mol.Wt. | 176.1 |
| INV STATUS | CUSTOM SYNTHESIS |
